Envestnet Asset Management Inc Amarin Corp Plcuk Transaction History

Envestnet Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.85 - $1.43 $7,771 - $13,074	9,143 Added 6.3%	154,275 $141,000
Q2 2023 Aug 04, 2023	BUY	$1.12 - $1.49 $117,803 - $156,721	105,182 Added 263.28%	145,132 $172,000
Q1 2023 May 11, 2023	SELL	$1.19 - $2.19 $67,763 - $124,707	-56,944 Reduced 58.77%	39,950 $59,000
Q4 2022 Feb 07, 2023	BUY	$1.07 - $1.34 $73,925 - $92,579	69,089 Added 248.48%	96,894 $117,000
Q3 2022 Nov 10, 2022	BUY	$1.09 - $1.67 $4,349 - $6,663	3,990 Added 16.75%	27,805 $30,000
Q2 2022 Aug 03, 2022	SELL	$1.13 - $3.69 $918 - $2,999	-813 Reduced 3.3%	23,815 $35,000
Q1 2022 May 04, 2022	SELL	$2.85 - $3.73 $2,379 - $3,114	-835 Reduced 3.28%	24,628 $81,000
Q4 2021 Feb 04, 2022	BUY	$3.24 - $5.18 $36,126 - $57,757	11,150 Added 77.9%	25,463 $86,000
Q3 2021 Oct 07, 2021	BUY	$3.94 - $5.84 $3,494 - $5,180	887 Added 6.61%	14,313 $73,000
Q2 2021 Aug 04, 2021	BUY	$4.26 - $6.5 $3,433 - $5,239	806 Added 6.39%	13,426 $59,000
Q1 2021 May 04, 2021	BUY	$5.03 - $8.8 $6,081 - $10,639	1,209 Added 10.6%	12,620 $78,000
Q4 2020 Feb 02, 2021	BUY	$4.04 - $5.31 $46,100 - $60,592	11,411 New	11,411 $56,000
Q1 2020 Apr 23, 2020	SELL	$4.0 - $21.53 $64,016 - $344,566	-16,004 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$13.94 - $24.12 $62,046 - $107,358	4,451 Added 38.53%	16,004 $343,000
Q3 2019 Oct 17, 2019	BUY	$13.89 - $23.16 $7,833 - $13,062	564 Added 5.13%	11,553 $175,000
Q2 2019 Aug 02, 2019	BUY	$16.27 - $20.51 $178,791 - $225,384	10,989 New	10,989 $213,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.